Grinda, Thomas http://orcid.org/0000-0002-8567-9627
Joyon, Natacha http://orcid.org/0000-0001-9742-267X
Lusque, Amélie
Lefèvre, Sarah
Arnould, Laurent
Penault-Llorca, Frédérique
Macgrogan, Gaëtan
Treilleux, Isabelle
Vincent-Salomon, Anne http://orcid.org/0000-0001-5754-5771
Haudebourg, Juliette
Maran-Gonzalez, Aurélie
Charafe-Jauffret, Emmanuelle
Courtinard, Coralie
Franchet, Camille
Verriele, Véronique
Brain, Etienne http://orcid.org/0000-0003-0881-9371
Tas, Patrick
Blanc-Fournier, Cécile
Leroux, Agnès
Loussouarn, Delphine
Berghian, Anca
Brabencova, Eva
Ghnassia, Jean Pierre
Scoazec, Jean-Yves
Delaloge, Suzette
Filleron, Thomas
Lacroix-Triki, Magali http://orcid.org/0000-0002-6641-8536
Article History
Received: 27 October 2020
Accepted: 24 March 2021
First Online: 16 April 2021
Competing interests
: S.D. reports grants and non-financial support from Pfizer, grants from Novartis, grants and non-financial support from AstraZeneca, grants and non-financial support from Roche Genentech, grants from Lilly, grants from Puma, grants from Myriad, grants from Orion, grants from Amgen, grants from Sanofi, grants from Genomic Health, grants from GE, grants from Servier, grants from MSD, grants from BMS, grants from Pierre Fabre, outside the submitted work. G.M. reports personal fees from ROCHE, personal fees from ASTRA ZENECA, personal fees from DAIICHI SANKYO, personal fees from MSD, personal fees from BMS, outside the submitted work. F.P.-L. reports personal fees from astrazeneca, grants from astrazeneca, grants from roche, personal fees from roche, personal fees from pfizer, personal fees from lilly, personal fees from novartis, grants from msd, personal fees from bms, grants from bms, personal fees from genomic health, grants from nanostring, grants from nanostring, personal fees from myriad, grants from myriad, grants from agendia, outside the submitted work. E.B. reports personal fees and other from Pfizer, personal fees and other from Roche, other from Pierre Fabre, grants, personal fees and other from BMS, personal fees from Samsung, other from Novartis, other from AstraZeneca, personal fees from TLC PharmaChem, personal fees from Clinigen, personal fees from Mylan, personal fees from G1 Therapeutics, personal fees from Lilly, outside the submitted work. T.G., N.J., A.L., S.L., L.A., I.T., A.V.-S., J.H., A.M.-G., E.C.-J., C.C., C.F., V.V. P.T., C.B.-F., A.L., D.L., E.B., A.B., J.P.G., T.F., M.L.-T. declare no competing interests.